Pulmonary tumours in the Netherlands: Focus on temporal trends in histology and stage and on rare tumours

Thorax

Volumn 63, Issue 12, 2008, Pages 1096-1102

  De Jong, W K ^a   Schaapveld, M ^b   Blaauwgeers, J L G ^c   Groen, H J M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Integraal Kankercentrum Noord Nederland   (Netherlands)

^c ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSQUAMOUS CARCINOMA; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CARCINOID; EARLY CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SARCOMA; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LUNG TUMOR; MAGNOCELLULAR NUCLEUS; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRIORITY JOURNAL; RARE DISEASE; SEX DIFFERENCE; SMOKING;

EID: 57149100438     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2007.095067     Document Type: Article

References (31)

1. Tyczynski JE, Bray F, Parkin DM. Lung cancer in Europe in 2000: epidemiology, prevention, and early detection. Lancet Oncol 2003;4:45-55.
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
3. Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents. Vol VIII. Lyon, France: International Agency for Research on Cancer, 2002.
4. Doll R, Hill AB. The mortality of doctors in relation to their smoking habits. A preliminary report. BMJ 1954;228:1451-5.
5. Devesa SS, Bray F, Vizcaino AP, et al. International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 2005;117:294-9.
6. Forey B, Hamling J, Lee P, et al. International smoking statistics: a collection of historical data from 30 economically developed countries. 2nd ed. Oxford: Oxford University Press, 2002.
7. Janssen-Heijnen ML, van Dijck JA, Siesling S, et al. [Lung cancer in the Netherlands in the period 1989-1997: the epidemic is not over yet]. Ned Tijdschr Geneeskd 2001;145:419-23.
8. STIVORO. www.stivoro.nl (accessed 6 December 2007).
9. Thun MJ, Lally CA, Flannery JT, et al. Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst 1997;89:1580-6.
10. Post PN, Casparie MK, ten Kate FJ, et al. [The epidemiology of tumors of the testes in the Netherlands: accurate rendering by the Registry of Histopathology and Cytopathology (PALGA)]. Ned Tijdschr Geneeskd 2004;148:1150-4.
11. Fritz AG, Percy C, Jack A, et al. International Classification of Diseases for Oncology (ICD-O). 3rd ed. Geneva: World Health Organization, 2000.
12. Statistics Netherlands (CBS). http://statline.cbs.nl/StatWeb/ (accessed 6 December 2007).
13. Piaterman RM, van Putten JW, Meuzelaar JJ. et al. Preoperattve staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 2000;343:254-61.
14. Shi AA, Digumarthy SR. Temel JS, et al. Does initial staging or tumor histology better identify asymptomatic brain metastases in patients with non-small cell lung cancer? J Thorac Oncol 2006;1:205-10
15. Mountain CF. The international system for staging lung cancer. Semin Surg Oncol 2000;18:106-15.
16. Bray F, Tyczynski JE, Parkin DM. Going up or coming down? The changing phases of the lung cancer epidemic from 1967 to 1999 in the 15 European Union countries. Eur J Cancer 2004;40:96-125.
17. Tyczynski JE, Bray F, Aareleid T, et al. Lung cancer mortality patterns in selected Central, Eastern and Southern European countries. Int J Cancer 2004;109:598-610.
18. Janssan-Heijnen ML, Coebergh JW. The changing epidemiology of lung cancer in Europe. Lung Cancer 2003;41:245-58.
19. Fu JB, Kau TY, Severson RK, et al. Lung cancer in women: analysis of the national Surveillance, Epidemiology, and End Results database. Chest 2005;127:768-77.
20. Khuder SA. Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis. Lung Cancer 2001;31:139-48.
21. Subramanian J, Govindan R. Lung cancer in never smokers: a review. J Clin Oncol 2007;25:561-70.
22. Travis WD, Colby TV, Corrin B, et al. World Health Organization international histological classification of tumors: histologic typing of lung and pleural tumors. 3rd ed. Berlin: Springer Verlag, 1999.
23. Asamura H, Kameya T, Matsuno Y, et al. Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol 2006;24:70-6.
24. Hage R, de la Riviere AB. Seldenrijk CA, et al. Update in pulmonary carcinoid tumors: a review article. Ann Surg Oncol 2003;10:697-704.
25. Skutadottir H, Hirsch FR, Hansen HH, et al. Pulmonary neuroendocrine tumors: incidence and prognosis of historical subtypes. A population-based study in Denmark. Lung Cancer 2002;37:127-35.
26. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer 1997;79:813-29.
27. Garcia-Yuste M, Matilla JM, Cueto A. et al. Typical and atypical carcinoid tumours: analysis of the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung. Eur J Cardiothorac Surg 2007;31:192-7. 28. Gawrychowski J, Brulinski K, Malinowski E, et al. Prognosis and survival after radical resection of primary adenosquamous lung carcinoma, Eur J Cardiothorac Surg 2005;27:686-92.
28. Kang SM, Kang HJ, Shin JH, et al. Identical epidermal growth factor receptor mutations in adenocarcinomatous and squamous cell carcinomatous components of adenosquamous carcinoma of the lung. Cancer 2007;109:581-7.
29. Nakagawa K, Yasumitu T, Fukuhara K, et al. Poor prognosis after lung resection for patients with adenosquamous carcinoma of the lung. Ann Thorac Surg 2003;75:1740-4.
30. Rosti G, Cavazza A, Sturm N, et al. Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: a clinicopathologic and immunohistochemical study of 75 cases. Am J Surg Pathol 2003;27:311-24.
31. Gladish GW, Sabloff BM, Munden RF, et al. Primary thoracic sarcomas. Radiographies 2002;22:621-37.